Relative Strength Chart Avacta Group Plc
Equities
AVCT
GB00BYYW9G87
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.00 GBX | +3.65% |
|
+11.81% | +22.41% |
| 24/02 | Avacta hails new data supporting proprietary preCision platform | AN |
| 24/02 | Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVACTA GROUP PLC | Bio Therapeutic Drugs | +3.65% | +11.81% | +22.41% | +98.32% | -64.32% | 40Cr |  |  | |
- Stock Market
- Equities
- AVCT Stock
- Charts Avacta Group Plc
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition